The molecular basis of anti-retroviral therapy.
Weber
J
J
St Mary's Hospital Medical School, London, UK.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000382:microbiology; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006678:HIV / Q000737:chemistry / Q000187:drug effects* / Q000254:growth & development; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors
D000998:Antiviral Agents; D015704:CD4 Antigens; D017320:HIV Protease Inhibitors; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; C076613:recombinant soluble CD4